BTG gene expression in the p53-dependent and -independent cellular response to DNA damage
- PMID: 10657898
BTG gene expression in the p53-dependent and -independent cellular response to DNA damage
Abstract
Exposure of mammalian cells to genotoxic agents evokes a complex cellular response. An ordered series of molecular events is necessary to sense DNA damage, transduce the signal, and ultimately delay the cell cycle or trigger apoptosis. Recently, we have shown that BTG2/TIS21 gene expression was induced in response to DNA damage through a p53-dependent pathway. This gene belongs to a newly identified family of structurally related genes whose other known human members are BTG1, BTG3, and Tob. To define the respective involvement of these four related genes in the cellular response to DNA damage, we studied their expression in human cell lines after a variety of genotoxic treatments. Our results demonstrated that were BTG1, BTG2/TIS21, and Tob genes the DNA damage--inducible genes. However, BTG2/TIS21 appeared to be the only p53-transcriptional target gene. We speculate that BTG proteins may play a coordinate role in a general transduction pathway that is induced in response to DNA damage. It has been previously described that recombinant BTG1 and BTG2/TIS21 can physically interact with PRMT1, an arginine methyl transferase, suggesting that BTG1 and BTG2/TIS21 induction may lead to posttranslational modifications of cellular proteins. In support of this hypothesis, we showed that the endogenous induction of BTG1 and BTG2 after genotoxic treatment was correlated with a modulation of protein methylation.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.Nat Genet. 1996 Dec;14(4):482-6. doi: 10.1038/ng1296-482. Nat Genet. 1996. PMID: 8944033
-
The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?J Cell Physiol. 2001 May;187(2):155-65. doi: 10.1002/jcp.1062. J Cell Physiol. 2001. PMID: 11267995 Review.
-
BTG2, its family and its tutor.Bull Cancer. 2004 Jul-Aug;91(7-8):E242-53. Bull Cancer. 2004. PMID: 15381462 Review.
-
[Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].Bull Cancer. 1999 Apr;86(4):358-64. Bull Cancer. 1999. PMID: 10341341 Review. French.
-
Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement.Exp Cell Res. 2007 Jul 1;313(11):2356-66. doi: 10.1016/j.yexcr.2007.03.021. Epub 2007 Mar 30. Exp Cell Res. 2007. PMID: 17466295
Cited by
-
Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray.BMC Cancer. 2010 Jun 16;10:296. doi: 10.1186/1471-2407-10-296. BMC Cancer. 2010. PMID: 20553615 Free PMC article.
-
Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.Tumour Biol. 2014 Dec;35(12):11771-9. doi: 10.1007/s13277-014-2298-x. Epub 2014 Aug 31. Tumour Biol. 2014. PMID: 25173640
-
The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.Mol Biol Rep. 2014 Sep;41(9):5979-88. doi: 10.1007/s11033-014-3475-0. Epub 2014 Jul 2. Mol Biol Rep. 2014. PMID: 24985971
-
Emerging role of anti-proliferative protein BTG1 and BTG2.BMB Rep. 2022 Aug;55(8):380-388. doi: 10.5483/BMBRep.2022.55.8.092. BMB Rep. 2022. PMID: 35880434 Free PMC article. Review.
-
Estrogen receptor prevents p53-dependent apoptosis in breast cancer.Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18060-5. doi: 10.1073/pnas.1018858109. Epub 2012 Oct 17. Proc Natl Acad Sci U S A. 2012. PMID: 23077249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous